Answers are grounded in this paper and cite their sources.
Conceptual framework defines a decision-driven data architecture in healthcare enterprises, suggesting improved reliability and governance for artificial intelligence deployments.
In the modern healthcare sector, enterprises globally face a critical challenge when deploying Artificial Intelligence (AI), Large Language Models (LLMs), and Retrieval-Augmented Generation (RAG) on top of raw clinical data. Traditional architectures often result in AI models delivering unreliable "hallucinations" or dashboards that fail to drive concrete strategic actions. This Reference Architecture addresses the root cause of this failure by establishing a fundamental principle: A sustainable healthcare intelligence platform must not begin with data collection; it must begin with decisions. This document defines the official Layer-1 Target Data Architecture and Enterprise Governance Framework for a scalable Healthcare Intelligence Platform. Aligned with international enterprise standards (TOGAF-aligned), this blueprint outlines the logical skeletons, data processing zones, and structural guardrails required to transform fragmented, multi-source operational data into trusted, decision-ready intelligence across a comprehensive 9-Section architecture flow. Key Areas Addressed in this Reference Architecture Framework: - Section 1: The Problem (Analyzing Modern Healthcare Data, Patient Identity Crises, and Terminology Barriers aligned with TOGAF Architecture Principles) - Section 2: The Demo & Platform Journey (Transforming Raw Data into an Integrated Target Data Architecture & Driving Proactive Enterprise Analytics) - Section 3 to 9: Enterprise Data Capabilities (Comprehensive logical frameworks outlining the end-to-end integration of Multi-Standard Semantic Layers supporting RxNorm/WHO-ATC, Patient Identity Resolution, Domain Data Mart Portfolios, and predictive Decision Intelligence roadmaps) Note: To safeguard proprietary enterprise intellectual property and maintain platform security, this document serves strictly as a conceptual and logical design reference. It intentionally excludes physical database schemas, localized terminology mapping metrics, unique scoring algorithms, and low-level source code. For healthcare enterprises, national health departments, or consulting agencies requiring custom Layer-2 logical data mart designs, custom medication ontology mapping (e.g., RxNorm, WHO-ATC, or local code structures), or full-scale physical implementation support, please contact the author directly to arrange a private strategic consulting engagement.
No takes yet. Share an insight, caveat, or question.
Chotika Ruangjun (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: